due to this , the prophylaxis and therapeutic policy should be aimed at the reduction of hormonal manifestations of the background ovarian structures in patients with ovarian endometriosis , endometrioid cysts and endometrioid adenocarcinomas .
C0029939
ovarian structures
C0156344
ovarian